Annual Revenue ($)

Gilead Sciences revenue was $24.69 b in FY, 2020

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$26.11 b$22.13 b$22.45 b$24.69 b
Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021
Revenue$6.51 b$7.14 b$6.51 b$5.09 b$5.65 b$5.6 b$5.28 b$5.69 b$5.6 b$5.55 b$5.14 b$6.58 b$6.42 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Gilead Sciences revenue breakdown by business segment: 98.5% from Product Sales and 1.5% from Other

Gilead Sciences revenue breakdown by geographic segment: 17.0% from Europe, 74.1% from United States and 8.9% from Other

FY, 2019FY, 2018FY, 2017
Royalty, Contract and Other Revenues330 m450 m445 m
Product Sales22.12 b21.68 b25.66 b
FY, 2019FY, 2018FY, 2017
Europe$3.81 b$4.01 b$5.31 b
United States$16.65 b$16.27 b$18.19 b
Other$1.99 b$1.85 b$2.6 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu